Jump Financial, LLC Immunome Inc. Transaction History

Jump Financial, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$11.7 - $16.51 $1.57 Million - $2.22 Million	-134,300 Closed	0 $0
Q2 2024 Aug 14, 2024	BUY	$11.54 - $22.11 $1.55 Million - $2.97 Million	134,300 New	134,300 $1.63 Million
Q4 2023 Oct 21, 2024	SELL	$7.3 - $10.73 $862,860 - $1.27 Million	-118,200 Reduced 88.01%	16,100 $172,000
Q4 2023 Feb 07, 2024	BUY	$7.3 - $10.73 $117,530 - $172,753	16,100 New	16,100 $172,000

122

47.1M

322K

1.91M

Ticker IMNM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,127,400
Market Cap $115M
Description
Immunome, Inc., a biopharmaceutical company, discovers and develops antibody therapeutics for oncology and infectious disease. The company's lead oncology program includes IMM-ONC-01, which targets IL-38 tumor-derived immune checkpoint capable of promoting evasion of the immune system. It also develops IMM-BCP-01, an antibody cocktail product ca...

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

Stay updated on Jump Financial, LLC with notifications on news.